Evaluation of selective-serotonin reuptake inhibitors and anti-androgens to manage sexual compulsivity in individuals serving a custodial sentence for a sexual offence
Open Access
- 16 April 2024
- journal article
- research article
- Published by Taylor & Francis in The Journal of Forensic Psychiatry & Psychology
- Vol. 35 (3) , 425-460
Abstract
No abstract availableKeywords
Funding Information
- NHS England
- Nottingham Trent University
This publication has 115 references indexed in Scilit:
- Pharmacological Treatments for Individuals with Paraphilic Disorders or at Risk for Sexual Offending2021
- Effect of Gonadotropin-Releasing Hormone Antagonist on Risk of Committing Child Sexual Abuse in Men With Pedophilic DisorderJAMA Psychiatry, 2020
- Pharmacological Treatment of Sexual Offenders2020
- The Pharmacological Treatment of Sex Offenders2018
- The Integrated Theory of Sexual Offending–Revised2016
- Prolonged flare‐up of testosterone after administration of a gonadotrophin agonist to a sex offender: an under‐recognised risk?Criminal Behaviour and Mental Health, 2015
- Pharmacological interventions for those who have sexually offended or are at risk of offendingCochrane Database of Systematic Reviews, 2015
- Understanding the Journeys of High‐Risk Male Sex Offenders Voluntarily Receiving Medication to Reduce Their Sexual Preoccupation and/or Hypersexuality2014
- Mindfulness, Emotional Dysregulation, Impulsivity, and Stress Proneness Among Hypersexual PatientsJournal of Clinical Psychology, 2013
- Sexual Offender Treatment2005